Accent Microcell Ltd vs Sanofi India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 03, 2026

Key Highlights

The Latest Trading Price of Accent Microcell Ltd is ₹ 425.35 as of 30 Apr 15:30 . The P/E Ratio of Accent Microcell Ltd is 0 as of December 2023 .The P/E Ratio of Sanofi India Ltd is 30.8 as of December 2023 . The Market Cap of Accent Microcell Ltd is ₹ 0 crore as of December 2023 .The Market Cap of Sanofi India Ltd is ₹ 18578 crore as of December 2023 . The Revenue of Accent Microcell Ltd is ₹ 0 crore as of Jun '24 .The Revenue of Sanofi India Ltd is ₹ 578.9 crore as of Jun '24 . The EBITDA of Accent Microcell Ltd is ₹ 0 crore as of Jun '24 .The EBITDA of Sanofi India Ltd is ₹ 178.5 crore as of Jun '24 . The Net Profit of Accent Microcell Ltd is ₹ 0 crore as of Jun '24 .The Net Profit of Sanofi India Ltd is ₹ 136.6 crore as of Jun '24 . The dividend payout of Accent Microcell Ltd changed from 8.96 % to 6.36 % over 5 quarters. This represents a CAGR of -23.98% The dividend payout of Sanofi India Ltd changed from 119.34 % to 0 % over 10 quarters. This represents a CAGR of -100.00% .

About Accent Microcell Ltd

Accent Microcell Limited was originally incorporated on April 10, 2012 as a Private Limited Company as 'Accent Microcell Private Limited' with the Registrar of Companies, Gujarat.
The Company converted from a Private Limited Company to Public Limited Company and , the name was changed to Accent Microcell Limited' and a Fresh Certificate of Incorporation was issued on December 23, 2022 by the Registrar of Companies, Ahmedabad. Presently, the Company manufacture Microcrystalline Cellulose (MCC) consisting Spray Dryer / Spin Flash Dried.
The Company is engaged in manufacturing of the high-quality cellulose-based excipients which predominantly find application in the Pharmaceutical, Nutraceutical, Food, Cosmetic and other industries. With 2 state-of-art manufacturing facilities located in Pirana (Unit -I) and Dahej SEZ (Unit -II).

About Sanofi India Ltd

Sanofi India Limited, was initially incorporated as 'Aventis Pharma Limited' in May, 1956.
The Company changed its name from Aventis Pharma Limited to Sanofi India Limited on May 11, 2012.
The Company is amongst the leading multinational companies (MNCs) in the Indian Pharmaceutical Market.
The Company is primarily engaged in the business of manufacturing and trading of drugs s and pharmaceuticals.
It has its own manufacturing facility at Goa.

FAQs for the comparison of Accent Microcell Ltd and Sanofi India Ltd

Which company has a larger market capitalization, Accent Microcell Ltd or Sanofi India Ltd?

Market cap of Accent Microcell Ltd is 1,020 Cr while Market cap of Sanofi India Ltd is 8,111 Cr

What are the key factors driving the stock performance of Accent Microcell Ltd and Sanofi India Ltd?

The stock performance of Accent Microcell Ltd and Sanofi India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Accent Microcell Ltd and Sanofi India Ltd?

As of May 3, 2026, the Accent Microcell Ltd stock price is INR ₹425.35. On the other hand, Sanofi India Ltd stock price is INR ₹3522.25.

How do dividend payouts of Accent Microcell Ltd and Sanofi India Ltd compare?

To compare the dividend payouts of Accent Microcell Ltd and Sanofi India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.